SCHEMBL22271050

SCHEMBL22271050

CNc1ccc(-c2nccnc2OC(C)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 4/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ NUDT1 P36639 1/20 0.39
▸ ADRA2A P08913 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ TSHR P16473 1/20 0.34
▸ ROCK2 O75116 1/20 0.34
▸ RPS6KA5 O75582 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ AKT1 P31749 1/20 0.34
▸ FLT4 P35916 1/20 0.34
▸ KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18448288 0.83 HTR6 (0.41) RORCHTR6NUDT1ADRA2AADRA2B
SCHEMBL19205732 0.83 HTR6 (0.41) RORCHTR6NUDT1ADRA2AADRA2B
SCHEMBL18449630 0.83 HTR6 (0.41) RORCHTR6NUDT1ADRA2AADRA2B
SCHEMBL19205707 0.78 ADRA2A (0.44) HTR6ADRA2AADRA2BADRA2CMAPK1
SCHEMBL18485952 0.78 ADRA2A (0.44) HTR6ADRA2AADRA2BADRA2CMAPK1
SCHEMBL18447791 0.78 ADRA2A (0.44) HTR6ADRA2AADRA2BADRA2CMAPK1
SCHEMBL22270578 0.74 ALDH1A1 (0.47) MAPK14
SCHEMBL18485943 0.67 L3MBTL1 (0.36) ADRA2AADRA2BADRA2CMAPK1AURKB
SCHEMBL31461385 0.66 HTR6 (0.46) RORCHTR6NUDT1ADRA2AADRA2B
SCHEMBL21254721 0.66 ALOX5AP (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback